We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

The Human Cost of Respiratory Care: Why Multidisciplinary Teams Cannot Shield Physicians from Burnout

MedXY Editorial Team•Mar 19, 2026•news
Burnoutcystic fibrosisHealthcare Workforceoccupational health

Highlights

  • Physicians in cystic fibrosis (CF) multidisciplinary teams report the highest levels of emotional exhaustion and depersonalization compared to other healthcare roles.
  • Administrative tasks and excessive documentation are the primary drivers of burnout, affecting over 79% of the workforce.
  • Significant demographic disparities exist, with Hispanic providers and female physicians facing unique challenges in personal accomplishment and help-seeking.
  • While team-based care is a gold standard for CF, it does not inherently protect against systemic stressors, necessitating institutional-level interventions.

Background: The Paradox of Team-Based Care

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Glucose Metabolism in Youths with Cystic Fibrosis: Insights from Continuous Glucose MonitoringThis study demonstrates that initiation of elexacaftor/tezacaftor/ivacaftor (ETI) therapy in children and adolescents with cystic fibrosis improves continuous glucose monitoring (CGM) metrics, correlating with better clinical outcomes.Sep 5, 2026Enhancing Resident Efficiency and Feedback through Personalized EHR Analytics CoachingIndividualized coaching using EHR learner analytics significantly improves resident inbasket management efficiency and feedback quality but does not reduce perceived burnout or improve confidence.Sep 3, 2026Evaluating Cell-Free DNA Testing for Autosomal Recessive Conditions in General-Risk Pregnancies: A Multicenter Prospective StudyThis prospective multicenter study demonstrates that cfDNA fetal risk screening accurately identifies autosomal recessive conditions in general-risk pregnancies with high specificity and improved positive predictive value compared to traditAug 18, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Strengthening Social Support Networks to Reduce Turnover in Primary Care Teams
This study highlights how enhanced social support within primary care teams correlates with lower turnover intentions, emphasizing the potential of network-based interventions to improve workforce stability and well-being in healthcare sett
Jul 7, 2026
Irregular Sleep Timing in Surgeons May Increase Postoperative Major Adverse EventsA multicenter prospective cohort study suggests that substantial surgeon social jet lag, but not midsleep variability alone, is associated with higher 30-day major adverse event risk after surgery and correlates with surgeon burnout.Jun 6, 2026
Transformative Survival Gains in Cystic Fibrosis: A Population-Level Evaluation of CFTR Modulator Therapy EffectivenessA large-scale retrospective study using US CFF Registry data reveals that CFTR modulator therapy reduces the hazard of death by 66% over an eight-year period, marking a significant milestone in cystic fibrosis clinical outcomes and life expMay 14, 2026